✦ LIBER ✦

Cytokine kinetic and response to interferon α (IFN) alone or in association with amantadine or ribavirin in HCV positive patients

✍ Scribed by F. Torre; S. Rossol; R. Giusto; R. Brizzolara; N. Sinelli; N. Campo; A. Picciotto

Book ID: 119526340
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 121 KB
Volume: 32
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(00)81006-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Kinetics of soluble tumour necrosis fact

Kinetics of soluble tumour necrosis factor (TNF)-α receptors and cytokines in the early phase of treatment for chronic hepatitis C: comparison between interferon (IFN)-α alone, IFN-α plus amantadine or plus ribavirin

✍ F. TORRE; S. ROSSOL; N. PELLI; M. BASSO; A. DELFINO; A. PICCIOTTO 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

13 P Interferon alpha plus ribavirin and

13 P Interferon alpha plus ribavirin and amantadine in chronic hepatitis C patients with previous non response or relapse to interferon and ribavirin

✍ A.Galeota Lanza; T. Ascione; W. Utech; G. Leone; A. Ascione 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Su1074 Meta-Analysis: Sustained Virologi

Su1074 Meta-Analysis: Sustained Virologic Response (SVR) in Patients With Infection With Hepatitis C Virus Genotype 5 (HCV-5) Versus Genotype 1 (HCV-1) and HCV Genotype 2/3 (HCV -2/3) Treated With Interferon (IFN) or Pegylated Interferon and Ribavirin (PEG IFN+RBV)

✍ Devaki, Pardha; Jencks, David S.; Nangia, Sharad; Marupakula, Vidyasagargoud; Ng 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 609 KB

Combined treatment with interferon alpha

Combined treatment with interferon alpha-2b and ribavirin for chronic hepatitis C in patients with a previous non-response or non-sustained response to interferon alone

✍ R. Schvarcz; Z. B. Yun; A. Sönnerborg; O. Weiland 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 2 views

Ten patients with chronic hepatitis C, six of whom had not responded and four of whom had responded in a non-sustained fashion to interferon-alpha treatment alone, were given interferon alpha-2b and ribavirin in combination during 24 weeks. Interferon alpha-2b was given subcutaneously, at a dose of

A randomized trial of pegylated-interfer

A randomized trial of pegylated-interferon-α2a plus ribavirin with or without amantadine in the re-treatment of patients with chronic hepatitis C not responding to standard interferon and ribavirin

✍ A. CIANCIO; A. PICCIOTTO; C. GIORDANINO; A. SMEDILE; M. TABONE; A. MANCA; G. MAR 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 464 KB

[6] VALOPICITABINE (NM283), ALONE OR WIT

[6] VALOPICITABINE (NM283), ALONE OR WITH PEG-INTERFERON, COMPARED TO PEG INTERFERON/RIBAVIRIN (PEGIFN/RBV) RETREATMENT IN PATIENTS WITH HCV-1 INFECTION AND PRIOR NON-RESPONSE TO PEGIFN/RBV: ONE-YEAR RESULTS

✍ N. Afdhal; C. O'Brien; E. Godofsky; M. Rodriguez-Torres; S.C. Pappas; E. Lawitz; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 127 KB